Conditions: Esophageal Neoplasms; Esophageal Diseases
Interventions: Radiation: 3-DCRT or IMRT radiation; Drug: anti-PD-1 antibody SHR-1210
Sponsors: Hangzhou Cancer Hospital; Jiangsu HengRui Medicine Co., Ltd.
Recruiting - verified June 2017
http://ift.tt/2tRO6MK
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου